Position in ABOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,556,833
+$324,292 QoQ
Shares Held
659,675
+12.9% QoQ
Ownership
0.913%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 84 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Derivatives in ABOS
reported options exposure · as of Sep 30, 2023CallValue
$223,270
CallShares
53,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. ABOS ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ABOS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,556,833 | 659,675 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,232,541 | 584,143 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,028,934 | 601,716 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,262,139 | 1,950,120 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,248,744 | 1,135,222 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,312,961 | 1,344,745 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,550,187 | 1,834,753 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,728,885 | 1,954,085 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,649,641 | 2,629,541 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,741,890 | 1,495,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $223,270 | 53,800 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $7,122,603 | 1,716,290 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $933,621 | 194,100 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $5,512,346 | 1,146,018 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,622,284 | 645,883 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,594,866 | 665,716 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,719,034 | 470,492 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $651,950 | 65,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $2,761,640 | 587,583 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $251,221 | 37,163 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||